Abstract
In this issue of Blood, Nakamura et al show that the SUMOylation inhibitor subasumstat (TAK-981) augments the ability of rituximab to evoke macrophage......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
